Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A detailed examination of the WHI E+P trial's enrollment biases, statistical caveats, generalizability gaps, and what subsequent peer commentary revealed about the study that reshaped HRT prescribing for two decades.
Read clinical reviewA deep-dive into the WHI E+P trial's randomization, blinding, endpoint definitions, statistical framework, and why each design choice shapes how clinicians should interpret the combined HRT results.
Read clinical reviewHow the Women's Health Initiative estrogen-plus-progestin trial reshaped HRT prescribing, which guidelines changed, and what the trial means for patients who don't match its population.
Read clinical reviewDeep-dive into cost-effectiveness analyses from the Women's Health Initiative estrogen-plus-progestin trial, including cost per QALY estimates, payer coverage shifts, and individual value calculations for combined HRT.
Read clinical reviewDeep dive into the Women's Health Initiative estrogen-plus-progestin trial follow-up and extension studies, covering long-term breast cancer, cardiovascular, and mortality outcomes after stopping combined HRT.
Read clinical reviewA granular breakdown of the Women's Health Initiative estrogen-plus-progestin trial results, including hazard ratios, confidence intervals, subgroup analyses, and the time-course pattern that reshaped HRT prescribing for two decades.
Read clinical reviewDeep-dive into the Women's Health Initiative estrogen-plus-progestin trial subgroup analyses by age, BMI, race/ethnicity, and baseline risk factors, revealing which women faced the highest and lowest risks from combined HRT.
Read clinical reviewA deep-dive overview of the Women's Health Initiative estrogen-plus-progestin trial, covering methodology, results, limitations, and what the findings mean for HRT prescribing today.
Read clinical review